Optimal Allocation of Sample Sizes to Multicenter Clinical Trials

By Lai Dejian   Chang Kuang-Chao   Rahbar Mohammad H.   Moye Lemuel A.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 4, 2013-07 ,pp. : 818-828

Taylor & Francis Ltd

Access to resources Recommend Favorite

Comparing the Response Rates for Superiority, Noninferiority and Equivalence Testing with Multiple-to-One Matched Binary Data

By Tsong Yi   Yuan Mengdie   Dong Xiaoyu   Wu Yu-te   Shen Meiyu  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 1, 2013-01 ,pp. : 98-109

Taylor & Francis Ltd

Access to resources Recommend Favorite

Statistical Considerations for Testing Multiple Endpoints in Group Sequential or Adaptive Clinical Trials

By Hung H. M. James  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1201-1210

Taylor & Francis Ltd

Access to resources Recommend Favorite

New Statistical Proposals to Evaluate the Benefit/Risk Ratio of Long-Term Treatment of Depression: Application to a One-Year Double-Blind Study Comparing Medifoxamine with Fluoxetine

By Lehert P.  

Clinical Drug Investigation, Vol. 15, Iss. 4, 1998-04 ,pp. : 285-295

Adis International

Access to resources Recommend Favorite

Vaccine Clinical Trials – A Statistical Primer

By Mehrotra D. V.  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 4, 2006-07 ,pp. : 403-414

Taylor & Francis Ltd

Access to resources Recommend Favorite